Skip to content

Pharma stocks slip on concerns over first anti-competitive US lawsuit against ‘Revlimid’ makers

The suit is expected to impact Natco Pharma, Dr Reddy#39;s Labs, Cipla, and Zydus Lifesciences. All these companies had launched Revlimid during the second COVID-19 wave in September 2021

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish